搜索筛选:
搜索耗时0.0940秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
发布年度:
[会议论文] 作者：YuqingLou,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Mitofusin-2gene(MFN2)encodesamitochondrialproteinwhichiscriticalformitochondrialfusionprocess.MFN2wasinitiallyidentifiedasahypertension-associatedgeneandimplicatedinthepath...
Chemotherapyisalsoanon-negligibleaspectofnon-smallcelllungcancer(NSCLC)treatmentinera
[会议论文] 作者：JianlinXu,BoJin,TianqinChu,YuqingLou,XueyanZhang,HuiminWang,BaohuiHan,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 ThediscoveryofEGFRasadrivinggeneinNSCLCheraldedthebeginningoftheeraofprecisionmedicineforNSCLC.ThisarticlereportedtreatmentpatternsandoutcomesofpatientswhoreceivedEGF...
Thecomparisonofoutcomesfromtyrosinekinaseinhibitorinfirst-,orsecond-lineforadvancednon
[会议论文] 作者：JianlinXu,xueyanZhang,BoJin,tianqinChu,HuimingWang,YuqingLou,baohuiHan,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Wesummarizetheclinicaldataofthispopulationandtheirsensitivitytofirst-，orsecond-lineEGFRTKItherapy.方法 AdvancedNSCLCpatientswith19delor21L858RwhousedtoreceiveEGFRTKIasf...
EGFRtyrosinekinaseinhibitorsversuschemotherapyasfirst-linetherapyfornon-smallcelllungca
[会议论文] 作者：JianlinXu,HaitangYang,BoJin,TianqinChu,XueyanZhang,YuqingLou,HuiminWang,BaohuiHan,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 TheefficacyofEGFRtyrosinekinaseinhibitors(TKIs)variesamongdifferentEGFRmutations.Here,wedirectlycomparedtheefficacyoffirst-lineTKIstochemotherapyfornon-smallcelllungcance...
[会议论文] 作者：yanweizhang,KeKeYu,SongHu,YuqingLou,JianlinXu,RongLi,XueyanZhang,BaohuiHan,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Theaimofthepresentstudywastoinvestigatetherelationshipbetweencirculatinginflammatorymakersandearlystagenon-smallcelllungcancer(NSCLC)risk.方法 Thepresentstudycollected228p...
[会议论文] 作者：BaohuiHan;LiwenXiong;JiayuanSun;RongLi;YuqingLou;YanweiZhang;AiqingGu;LiyanJiang;JianxinShi;WentaoFang,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Background: Concurrent chemoradiation therapy or induction chemotherapy plus surgery were considered as standard treatment to non-small-cell lung cancer (NS...
FactorsthatPredictProgression-freeSurvivalinChineseLungAdenocarcinomaPatientsTreatedwith
[会议论文] 作者：ShaohuaCui,LiwenXiong,YuqingLou,HuangpingShi,AiqinGu,YizhuoZhao,TianqingChu,HuiminWang,WeiZhang,LiliDong,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Althoughfirst-generationepidermalgrowthfactorreceptortyrosinekinaseinhibitors(EGFR-TKIs)haveshownefficacyinpatientswithadvancedlungcancers,survivalpredictorswiththesedrugsha...
Combination of chemotherapy and gefitinib as first-line treatment of patients with advanced lung ade
[会议论文] 作者：BaohuiHan,BoJin,TianqinChu,YanjieNiu,HuaZhong,YuDong,AiqingGu,HuiminWang,XueyanZhang,PingGu,YuqingLou,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 To explore the optimal treatment strategy for patients who harbored a sensitive EGFR mutation.We did a head-to-headstudy to compare chemotherapy and gefitinib in combination with either agent alone...
[会议论文] 作者：RongLi[1]JinsuHuang[1]MeiliMa[1]YuqingLou[1]YanweiZhang[1]LixiaWu[2]Davidw.Chang[3]PichengZhao[4]QianggangDong,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Stem-like cells in solid tumors are purported to contribute to cancer development and poor treatment outcome.The abilities to self-renew, differe...
相关搜索：
